LATEST
Janel agreed to acquire EnCor BiotechnologynewNightfood Holdings acquired Jun Long Machine IndustrialnewClimb Global Solutions acquired NeoVADnewValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range IntermediateBose acquired Skullcandy
Open App
Agreement signedPublished 7 Sep 2022

Arcutis Biotherapeutics, Inc. /
Ducentis Biotherapeutics LTD.

Arcutis to buy Ducentis Biotherapeutics LTD.

Price
$30m
Stage
Agreement signed
Source · 7 Sep 2022
See the source
01 / BuyerArcutis Biotherapeutics, Inc.
02 / TargetDucentis Biotherapeutics LTD.
01

What happened

Arcutis Biotherapeutics, Inc. agreed to acquire Ducentis Biotherapeutics LTD. in a share purchase agreement. The transaction includes approximately $30 million in upfront consideration, plus contingent payments tied to development, regulatory and commercial milestones.

Ducentis is a preclinical-stage biotechnology company developing therapies for inflammation and autoimmune diseases.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Arcutis to buy Ducentis Biotherapeutics LTD.

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.